Journal: iScience

Article Title: PBX3 regulates mast cell parthanatos via TOP2A mediated DNA damage in allergic rhinitis

doi: 10.1016/j.isci.2026.115426

Figure Lengend Snippet: Regulatory role of TOP2A in mast cell apoptosis, parthanatos pathway, and inflammatory response In vitro experimental groups: CON, model, Model+OE-NC, Model+OE-TOP2A, Model+si-NC, Model+si-TOP2A. (A and B) RT-qPCR and western blot analyses were conducted to assess the mRNA and protein expression levels of TOP2A and PARP-1 in mast cells. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. the CON or Model+OE-NC or Model+si-NC group. (C) TUNEL staining was performed to evaluate and visualize cell apoptosis. ∗ p < 0.05, ∗∗ p < 0.01 vs. the CON or Model+OE-NC or Model+si-NC group; scale bars, 50 μm. (D) Cell proliferation activity in each group was measured using the CCK-8 assay. ∗∗ p < 0.01 vs. the CON or Model+OE-NC or Model+si-NC group. (E and F) MMP was assessed using the JC-1 assay to evaluate mitochondrial function. ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. the CON or Model+OE-NC or Model+si-NC group. (G) Western blotting was used to examine the protein levels of mitochondrial AIF (Mito-AIF), cytoplasmic AIF (Cyto-AIF), and nuclear AIF (Nucleo-AIF), along with visual analysis. ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. the CON or Model+OE-NC or Model+si-NC group. (H and I) ELISA was employed to determine the concentrations of β-hexosaminidase, Histamine, IL-4, IL-5, and IFN-γ. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. the CON or Model+OE-NC or Model+si-NC group. Data are represented as mean ± SEM ( n = 3 per group) from independent biological replicates. One-way ANOVA with Tukey’s post hoc correction for (A–D) and (F–I).

Article Snippet: Cells were then incubated overnight at 4°C with a primary antibody against PARP-1 (PB9309, BOSTER, Pleasanton, CA, USA, 1:100).

Techniques: In Vitro, Quantitative RT-PCR, Western Blot, Expressing, TUNEL Assay, Staining, Activity Assay, CCK-8 Assay, Enzyme-linked Immunosorbent Assay

Journal: iScience

Article Title: PBX3 regulates mast cell parthanatos via TOP2A mediated DNA damage in allergic rhinitis

doi: 10.1016/j.isci.2026.115426

Figure Lengend Snippet: Effects of TOP2A on DNA damage, parthanatos regulation, and degranulation in mast cells Experimental groups: Model+OE-NC, Model+OE-TOP2A, Model+si-NC, Model+si-TOP2A. (A) Western blotting was employed to determine the protein expression levels of γ-H2AX. ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. the Model+OE-NC or Model+si-NC group. (B and C) IF staining was performed to assess the expression of the DNA damage marker γ-H2AX in mast cells. ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. the Model+OE-NC or Model+si-NC group; scale bar = 50 μm. (D) Cellular senescence was evaluated using an SA-β-gal staining kit. ∗ p < 0.05, ∗∗ p < 0.01 vs. the Model+OE-NC or Model+si-NC group; scale bars, 50 μm. Experimental groups: Model+OE-NC, Model+OE-TOP2A, Model+OE-TOP2A + DOX. (E and F) RT-qPCR and western blot analyses were conducted to detect the gene and protein expression levels of TOP2A and PARP-1 under different treatment conditions. ∗∗∗ p < 0.001 vs. the Model+OE-NC or Model+OE-TOP2A group; ns, not significant ( p ≥ 0.05). (G) Western blotting was employed to determine the protein expression levels of γ-H2AX. ∗∗∗ p < 0.001 vs. the Model+OE-NC or Model+OE-TOP2A group. (H) IF staining was used to evaluate γ-H2AX expression as a marker of DNA damage. ∗ p < 0.05, ∗∗∗ p < 0.001 vs. the Model+OE-NC or Model+OE-TOP2A group; scale bars, 50 μm. (I) SA-β-gal staining was used to assess cellular senescence. ∗ p < 0.05, ∗∗ p < 0.01 vs. the Model+OE-NC or Model+OE-TOP2A group; scale bars, 50 μm. (J) Western blot analysis was used to determine the protein expression levels of Mito-AIF, Cyto-AIF, and Nucleo-AIF. ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. the Model+OE-NC or Model+OE-TOP2A group. (K and L) ELISA assays were carried out to measure the levels of β-hexosaminidase, Histamine, IL-4, IL-5, and IFN-γ. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. the Model+OE-NC or Model+OE-TOP2A group. Data are represented as mean ± SEM ( n = 3 per group) from independent biological replicates. one-way ANOVA with Tukey’s post hoc correction for (A and C–L).

Article Snippet: Cells were then incubated overnight at 4°C with a primary antibody against PARP-1 (PB9309, BOSTER, Pleasanton, CA, USA, 1:100).

Techniques: Western Blot, Expressing, Staining, Marker, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay

Journal: iScience

Article Title: PBX3 regulates mast cell parthanatos via TOP2A mediated DNA damage in allergic rhinitis

doi: 10.1016/j.isci.2026.115426

Figure Lengend Snippet: Effects of PBX3 silencing on mast cell function and DNA damage response Experimental groups: Model+si-NC, Model+ si-PBX3. (A) RT-qPCR and western blot analyses were conducted to evaluate the mRNA expression levels of PBX3 and TOP2A. ∗∗∗ p < 0.001 vs. the Model+si-NC group. (B–D) Western blotting and IF staining were used to assess the expression of the DNA damage marker γ-H2AX. ∗ p < 0.05, ∗∗∗ p < 0.001 vs. the Model+si-NC group; scale bars, 50 μm. (E) SA-β-gal staining was performed to detect cellular senescence. ∗∗ p < 0.01 vs. the Model+si-NC group; scale bars, 50 μm. (F–H) RT-qPCR, western blotting, and IF staining were employed to examine PARP-1 expression in mast cells. ∗∗∗ p < 0.001 vs. the Model+si-NC group; scale bars, 50 μm. (I) Western blot analysis was used to detect the protein levels of Mito-AIF, Cyto-AIF, and Nucleo-AIF. ∗∗∗ p < 0.001 vs. the Model+si-NC group. (J and K) ELISA assays were conducted to quantify the levels of β-hexosaminidase, histamine, IL-4, IL-5, and IFN-γ in mast cells. ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. the Model+si-NC group. Data are represented as mean ± SEM ( n = 3 per group) from independent biological replicates. Two-tailed unpaired Student’s t tests for (A, B, D–G, and I–K).

Article Snippet: Cells were then incubated overnight at 4°C with a primary antibody against PARP-1 (PB9309, BOSTER, Pleasanton, CA, USA, 1:100).

Techniques: Cell Function Assay, Quantitative RT-PCR, Western Blot, Expressing, Staining, Marker, Enzyme-linked Immunosorbent Assay, Two Tailed Test

Journal: iScience

Article Title: PBX3 regulates mast cell parthanatos via TOP2A mediated DNA damage in allergic rhinitis

doi: 10.1016/j.isci.2026.115426

Figure Lengend Snippet: PBX3 drives DNA damage through TOP2A to regulate mast cell parthanatos, senescence, and degranulation Experimental groups: Model+si-NC, Model+si-PBX3, Model+si-PBX3+OE-NC, Model+si-PBX3+OE-TOP2A. (A) Western blot analysis was performed to determine protein expression levels of PBX3, TOP2A, PARP-1, and γ-H2AX. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. the Model+si-NC or Model+si-PBX3+OE-NC group; ns, not significant ( p ≥ 0.05). (B) IF staining was conducted to detect the DNA damage marker γ-H2AX. ∗∗∗ p < 0.001 vs. the Model+si-NC or Model+si-PBX3+OE-NC group; scale bars, 50 μm. (C) Cellular senescence was assessed using an SA-β-gal staining kit. ∗∗∗ p < 0.001 vs. the Model+si-NC or Model+si-PBX3+OE-NC group; scale bars, 50 μm. (D) ELISA was employed to measure the levels of degranulation markers β-hexosaminidase and histamine. ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. the Model+si-NC or Model+si-PBX3+OE-NC group. (E) Cytokine levels of IL-4, IL-5, and IFN-γ in cell supernatants were quantified by ELISA. ∗ p < 0.05, ∗∗∗ p < 0.001 vs. the Model+si-NC or Model+si-PBX3+OE-NC group. Data are represented as mean ± SEM ( n = 3 per group) from independent biological replicates. One-way ANOVA with Tukey’s post hoc correction for (A–E).

Article Snippet: Cells were then incubated overnight at 4°C with a primary antibody against PARP-1 (PB9309, BOSTER, Pleasanton, CA, USA, 1:100).

Techniques: Western Blot, Expressing, Staining, Marker, Enzyme-linked Immunosorbent Assay

Journal: Molecular Oncology

Article Title: HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer

doi: 10.1002/1878-0261.12883

Figure Lengend Snippet: HSP90 pharmacological inhibition or HSP90α knockout increases the pro‐apoptotic and DNA damage effect of CDDP in Pt‐res TOV‐112D cells. (A) Apoptosis and necrosis evaluated by flow cytometry after Annexin V‐FITC and propidium iodide staining in TOV‐112D Pt‐res cl. 7 and (B) cl. 2 cells, untreated or treated for 48 h (upper panels) or 72 h (lower panels), with CDDP and/or ganetespib at IC 50 72 h doses of parental cells. (C) Western blot analysis of γH2AX, PARP1 and caspase 3 cleavage, BAX and BCL2 expression, in TOV‐112D Pt‐res pool 2 cells untreated or treated with CDDP and/or ganetespib at the doses indicated above. β‐Actin expression serves as loading control. Western blot quantification was performed by imagej software. (D) Apoptosis and necrosis evaluated by flow cytometry after Annexin V‐FITC and propidium iodide staining in TOV‐112D, TOV‐112D Pt‐res cl. 7 and in HSP90α knockout TOV‐112D Pt‐res KO#2 cells, untreated or treated for 48 or 72 h with CDDP at IC 50 72 h doses of parental cells.

Article Snippet: Primary antibodies were purchased as follows: HSP90 alpha 2G5.G3 (#SMC‐147) and HSP90 (total) 4F3.E8 (#SMC‐149) from StressMarq Biosciences (Victoria, BC, Canada); GRP75 (#3593), LMN A/C (#2032), ANXA1 (#3299), Bax (#2774), CASPASE 3 (#9662), cleaved PARP1 (Asp214; #5625), PARP1 (#9542), Bcl‐2 (#4223S) from Cell Signaling Technology (Leiden, Netherlands); VIM (ab 16700), prohibitin (PHB; ab55618), CALR (ab2907), heat‐shock cognate 71‐kDa protein (HSP7C; ab19136), PGK1 (ab67335), PRDX4 (ab15574) from Abcam (Cambridge, UK); GRP78 C‐20 (sc‐1051), EZR H‐276 (sc‐20773), β‐actin C4 (sc‐47778), and GAPDH (FL‐335) from Santa Cruz Biotechnology Inc., (Dallas, TX, USA); VINC (10C‐CR1199M1) from Fitzgerald (Acton, MA, USA); ɣH2AX (Ser139) clone JBW301 (#05‐636) from Millipore (Burlington, MA, USA); and heterogeneous nuclear ribonucleoprotein L (HNRPL; A303‐895A) from Bethyl (Montgomery, TX, USA).

Techniques: Inhibition, Knock-Out, Flow Cytometry, Staining, Western Blot, Expressing, Software

Journal: Molecular Oncology

Article Title: HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer

doi: 10.1002/1878-0261.12883

Figure Lengend Snippet: Potentiation of CDDP antitumor effect induced by ganetespib in vivo CDDP‐resistant TOV‐112D xenograft model. TOV‐112D Pt‐res pool 2 cells (5 × 10 6 ) were s.c. injected into NSG mice as described in . When tumors were established, mice (five/group) were treated once a week for two weeks, with CDDP (2.5 mg·kg −1 i.p.), ganetespib (GANE; 75 mg·kg −1 i.p.), both drugs in combination, or their respective vehicles (UNT). (A) Relative TV measured at prespecified time points (Means ± SEM). (B) TVs at cutoff when mice were sacrificed. Data are shown as means ± SEM. (C) Mice body weight as surrogate indicator of toxicity for in vivo experiment reported in A. Body weight was measured three times/week. (D) TGD, indicating the mean rate of tumor growth in the treatment groups relative to control untreated mice (see ). Statistically significant results calculated with one‐way ANOVA test are reported (* P < 0.05, ** P < 0.01, and *** P < 0.001). (E) Western blot analysis of γH2AX, cleaved PARP1, cleaved caspase 3, HSP90α, and total HSP90, in lysates from three representative xenograft tumor samples from each treatment group (see ). β‐Actin expression serves as loading control. Western blot quantification was performed by imagej software using the mean value of the three samples for each experimental group.

Article Snippet: Primary antibodies were purchased as follows: HSP90 alpha 2G5.G3 (#SMC‐147) and HSP90 (total) 4F3.E8 (#SMC‐149) from StressMarq Biosciences (Victoria, BC, Canada); GRP75 (#3593), LMN A/C (#2032), ANXA1 (#3299), Bax (#2774), CASPASE 3 (#9662), cleaved PARP1 (Asp214; #5625), PARP1 (#9542), Bcl‐2 (#4223S) from Cell Signaling Technology (Leiden, Netherlands); VIM (ab 16700), prohibitin (PHB; ab55618), CALR (ab2907), heat‐shock cognate 71‐kDa protein (HSP7C; ab19136), PGK1 (ab67335), PRDX4 (ab15574) from Abcam (Cambridge, UK); GRP78 C‐20 (sc‐1051), EZR H‐276 (sc‐20773), β‐actin C4 (sc‐47778), and GAPDH (FL‐335) from Santa Cruz Biotechnology Inc., (Dallas, TX, USA); VINC (10C‐CR1199M1) from Fitzgerald (Acton, MA, USA); ɣH2AX (Ser139) clone JBW301 (#05‐636) from Millipore (Burlington, MA, USA); and heterogeneous nuclear ribonucleoprotein L (HNRPL; A303‐895A) from Bethyl (Montgomery, TX, USA).

Techniques: In Vivo, Injection, Western Blot, Expressing, Software

Journal: bioRxiv

Article Title: Non-DNA-damaging DNA-PK activation improving hearing and prolonging life due to NAD + and SIRT upregulation

doi: 10.1101/2025.04.18.649305

Figure Lengend Snippet: a, Separation of MA-5 R-enantiomer and S-enantiomer from MA-5 racemic body by the chiral column (upper). The chemical inversion/conversion of R -and S- enantiomer of MA-5 were not observed in a rhesus monkey administered each enantiomer (lower). b , Intracellular ATP measurement of HEI-OC1 cells with various concentration of MA-5, S-enantiomer and R-enantiomer at 0, 1, 3,10, 30 and 100nM for 6hr. Data were mean ± SE.* p <0.05, ** p <0.01 vs. DMSO control; statistics were calculated by One way anova Durnett’s multiple comparison test. c , The cell-protective effect of MA-5 S-enantiomer and R-enantiomer against cytotoxicity of BSO in skin fibroblasts from a MELAS patient. MELAS patient skin fibroblasts were cultured with BSO at 500μM through various concentrations of MA-5 S-enantiomer (left) or R-enantiomer (right) at 10, 30, 100, 300nM, 1 μM, 3μM 10 μM and 100 μM for 72hrs. Cell viability and cytotoxicity were measured by WST-8 assay. Data were mean ± SE.* p <0.05, ** p <0.01, *** p <0.001 vs 0.1% DMSO control; statistics were calculated by One way anova Durnett’s multiple comparison test. d, Intracellular NAD + measurement of HEI-OC1 cells. HEI-OC1 cells were treated with 0.1 % DMSO or MA-5 racemate, MA-5 S-enantiomer and R- enantiomer at 3,10, 30 and 100nM for 6hr. Data were mean ± SE. * p <0.05, ** p <0.01 vs. DMSO control; statistics were calculated by One way anova Durnett’s multiple comparison test. e , Intracellular NAD + measurement of human iPS-induced inner ear cells. Human iPS-induced inner ear cells were treated with 0.1 % DMSO or MA-5 racemate, MA-5 S-enantiomer and R-enantiomer at 3,10, 30 and 100nM for 6hr. Data were mean ± SE. * p <0.05, ** p <0.01 vs. DMSO control; statistics were calculated by One way anova Durnett’s multiple comparison test. f, The effects of S-enantiomer on SIRT1 enzymatic activity. The effects of S- enantiomer on SIRT1 deacetylase activity in vitro at 10,30 and 100 μM (left). The effects of S-enantiomer on SIRT1 deacetylase activity in cell nuclear fraction extract from HEI-OC1 cells treated with S-enantiomer at 10 and 30 μM for 3hr (right). Data were mean ± SE.* p <0.05, ** p <0.01 vs. DMSO control; statistics were calculated by One way anova Durnett’s multiple comparison test. g, The acetylation of p53 (K305) was reduced by MA-5 S enantiomer. The effects of S-enantiomer on the acetylation of p53 (K305) in whole cell extraction from HEI-OC1 cells treated with MA-5 racemate and S-enantiomer at 10 and 30 μM for 24hr. h , The cellular localization of PARylation in HEI-OC1 cells treated with 0.1 % DMSO or MA-5 at 10μM for 24hr. (left). Poly-ADP ribosylation of PARP protein in HEI-OC1 cells treated with 0.1 % DMSO, MA-5 racemate, S-enantiomer and R-enantiomer at 30 100μM for 24hr. i , Immunocyto-staining of H2AX phosphorylated (γH2AX) of HEI-OC1 cells treated with 0.1 % DMSO, doxiorubicin (Dox) at 0.3μM, MA-5, S-enantiomer and R-enantiomer at 30 μM for 24hr. Representative (Upper). Florescence intensities of γH2AX immunocytostaining were measured (Lowere). Data were mean ± SE. p <0.05, ***: p <0.0001 vs. control. # p <0.05, #### p <0.0001 vs. Dox 0.3μM; statistics were calculated by One way anova Durnett’s multiple comparison test. j , Immunocytostaining of H2AX phosphorylated (γH2AX) of HEI-OC1 cells treated with 0.1 % DMSO, camptothecin (Capt) at 1μM, MA-5, S-enantiomer and R-enantiomer at 30 μM for 24hr. Representative (Upper). Florescence intensities of γH2AX immunocytostaining were measured (Lowere). Data were mean ± SE. p <0.05, ***: p <0.0001 vs. control. # p <0.05, #### p <0.0001 vs. Capt 1μM; statistics were calculated by One way anova Durnett’s multiple comparison test. k , The NAMPT enzymatic activity in vitro treated with MA-5, S-enantiomer and R- enantiomer at 3,10, 30 and 100nM for 1hr. Data were mean ± SE. * p <0.05, ** p <0.01 vs. DMSO control; statistics were calculated by One way anova Durnett’s multiple comparison test. l, The NAMPT enzymatic activity in vitro treated with S-enantiomer at 10 and 100μM with or without selective NAMPT inhibitor FK-866 at 10nM ( left ). Data were mean ± SE.* p <0.05, ** p <0.01 vs. DMSO control; statistics were calculated by One way anova Durnett’s multiple comparison test. The Inhibitory curve on NAMPT activity with various concentration of FK-866 at at 10, 20, 30, 40 and 50nM ( right ). The Inhibitory curve on NAMPT activity with FK-866 was shifted by addition of MA-5 S-enantiomer at 100 μM ( right ). * p <0.05, ** p <0.01 vs. FK-866 alone inhibitory curve; s statistics were calculated by unpaired two-side t-test. m , The binding between NAMNPT and MA-5, MA-5 S-enantiomer and R-enantiomer and FK-866 were quantitatively analyzed using Biolayer Interferometry (BLI). n , In silico study of Mitochonic acid 5 binding to NAMPT. (a) Possible binding sites on NAMPT of MA-5 S-enantiomer and R-enantiomer. (b) The binding interaction scores of MA-5 S-enantiomer and R-enantiomer at sites ( i ) and ( ii ). (c) The binding conformations of MA-5 S-enantiomer and R-enantiomer at sites ( i ) and ( ii ). (d) the conformational dynamics of ligand binding of MA-5 S-enantiomer and R-enantiomer. (e)

Article Snippet: Antibodies from the following companies were used for Western blot analysis: SIRT1 (1:1000 dilution, #9475, Cell Signaling), SIRT2 (1:1000 dilution, #12650, Cell Signaling), SIRT3 (1:1000 dilution, #5490, Cell Signaling), SIRT4 (1:1000 dilution, #69786, Cell Signaling), SIRT5(1:1000 dilution, #8782, Cell Signaling), SIRT6 (1:1000 dilution, #12486, Cell Signaling), SIRT7(1:1000 dilution, sc-365344,Santa Cruz), IMMT/Mitofilin (1:1000 dilution, 10179-1-AP, ProteinTech), p53 (1:1000 dilution, #2524, Cell Signaling), acertyl p53(K305) (1:1000 dilution, ab109396, abcam), Phospho-p53 (Ser15) (1:1000 dilution, #9284, Cell Signaling), TRIM28(KAP1)(1:10000 dilution, ab109287, abcam), 4H11 pTRIM28 (Ser 473) mouse mAb(1:1000 dilution, Gift from Dr .Shunsuke Chikuma), pTRIM28(KAP1) (Ser 824) (1:1000 dilution, ab133440, abcam), ATM (1:1000 dilution, #2873, Cell Signaling), pATM(Ser 1981)(1:1000 dilution, Invitrogen #14-9046-82), DNA-PKcs (1:1000 dilution, #4602, Cell Signaling), pDNA-PKcs(Ser 2056) (1:1000 dilution, ab18192, abcam), K48-linkage Specific Polyubiquitin (1:1000 dilution, #4289, Cell Signaling), FLAG® tag epitope(DYKDDDDK tag) (1:1000 dilution, F1804, Sigma Aldrich), MYC Tag (1:1000 dilution, #2278, Cell Signaling), PARP1 (1:1000 dilution, #9542, Cell Signaling), PARP1, acetyl Lys521 (1:1000 dilution, CSB-PA890185, CUSABIO), poly(ADP-ribose) polymer (pADPr) (1:1000 dilution, sc-56198, Santa Cruz), 53BP1 (1:1000 dilution, ab175933, Abcam), Phospho-53BP1 (Ser25) (1:1000 dilution, NB100-1803, Novus Biologicals), Acetyl-Histone H3 (Lys18) (1:1000 dilution, #9675, Cell Signaling), Phospho-Chk2 (Thr68) (1:1000 dilution, E-AB-20843, Elabscience), DNA PKcs (pS2056) (1:1000 dilution, ab124918, Abcam), GAPDH (1:1000 dilution, sc-32233, Santa Cruz), β-actin (1:500 dilution, sc-47778, Santa Cruz).

Techniques: Concentration Assay, Control, Comparison, Cell Culture, Activity Assay, Histone Deacetylase Assay, In Vitro, Extraction, Staining, Binding Assay, In Silico, Ligand Binding Assay

Journal: PLoS ONE

Article Title: Wogonin Has Multiple Anti-Cancer Effects by Regulating c-Myc/SKP2/Fbw7α and HDAC1/HDAC2 Pathways and Inducing Apoptosis in Human Lung Adenocarcinoma Cell Line A549

doi: 10.1371/journal.pone.0079201

Figure Lengend Snippet: (A) Analysis of the mitochondrial membrane potential (ΔΨm) using JC-1 staining after exposure to wogonin for 48 h. A fluorescence microscope was used to visualize the results. Mitochondrial depolarization was indicated by an increase in green fluorescence and a decrease in red fluorescence intensity. (B) Protein levels of Bcl-2, Mcl-1, XIAP, survivin and PARP assayed by western blot. (C) Cytoplasmic proteins were extracted for western blot analysis of released Cytochrome c and AIF. In these experiments, cells were exposed to wogonin 0, 15, 25, 35 µg/mL for 48 h. * P <0.05 vs control group, ** P <0.01 vs control group.

Article Snippet: The following antibodies were used: Fbw7(Cdc4, H-300) and p-c-Myc (Thr 58) (Santa Cruz, USA); c-Myc, GSK3β, AIF (apoptosis inducing factor, Proteintech Group, Inc., USA); HDAC1, HDAC2, Skp2, Survivin, Bcl-2 (B-cell lymphoma 2), β-Actin (Boster, China); Mcl-1 (myeloid cell leukemia sequence 1), XIAP(X-linked inhibitor of apoptosis protein, Bioss, China); Cytochome c (KeyGEN, China); PARP (poly ADP-ribose polymerase, Sino Biological Inc., China).

Techniques: Staining, Fluorescence, Microscopy, Western Blot

Journal: The Journal of Experimental Medicine

Article Title: Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome

doi: 10.1084/jem.20191688

Figure Lengend Snippet: Knockdown of ZBTB24 does not affect cell cycle progression and the expression of genes involved in DSB repair. ICF2 patient-derived fibroblasts and ZBTB24 KO U2OS cells are not sensitive to IR (related to ). (A) U2OS cells and HEK293T cells containing the EJ5-GFP reporter were treated with the indicated siRNAs. WCEs were prepared 48 h later and subjected to Western blot analysis for ZBTB24. RAD51 is a loading control. (B) HEK293T cells containing the EJ5-GFP reporter were transfected with the indicated siRNAs. 48 h later, cells were transfected with a control vector or the I- Sce I expression vector (pCBASce). After an additional 24 h, cells were subjected to propidium iodide staining followed by flow cytometry analysis. The percentage of cells in G1 (red bar), S (blue bar), and G2/M (green bar) phase is presented. The mean ± SEM from two independent experiments is shown. Statistical significance was calculated using Student’s t test (ns, not significant). (C) Schematic of the GC92 reporter for NHEJ. (D) Fibroblasts containing the GC92 reporter were treated with the indicated siRNAs and, 48 h later, cotransfected with I- Sce I (pCBASce) and mCherry expression vectors. The ratio of CD4-FITC/mCherry-expressing cells was counted by flow cytometry 48 h later. The mean ± SEM from three to four independent experiments is shown. Statistical significance was calculated using Student’s t test (**, P < 0.01; ****, P < 0.0001). (E) Cells from D were subjected to Western blot analysis of KU80 and ZBTB24 expression. Tubulin and RAD51 are loading controls. (F) U2OS cells were treated with the indicated siRNAs. WCEs were prepared 48 h later and subjected to Western blot analysis for DNA-PKcs and PARP1. Tubulin is a loading control. (G) HEK293T cells were treated with control siRNAs against luciferase or three different siRNAs against ZBTB24. 4 d later, RNA was isolated and subjected to RNA sequencing analysis. The number of genes found to be commonly misregulated after ZBTB24-depletion with each of the siRNAs is presented (false discovery rate < 0.05). Importantly, gene ontology term term analysis (0006302; DSB repair) did not reveal the presence of DSB repair genes among the misregulated genes. (H) ICF2 patient-derived fibroblasts were exposed to different doses of IR and scored for clonogenic survival. The mean ± SEM from two independent experiments is shown. (I) ZBTB24 KO U2OS cells were exposed to different doses of IR and scored for clonogenic survival. The mean ± SEM from two independent experiments is shown. (J) Western blot analysis of ZBTB24 and CDCA7 expression in ZBTB24 KO U2OS clones from I. Tubulin is a loading control. (K) TIDE analysis of ZBTB24 KO clones from I , showing 17- and 13-bp out-of-frame deletions in ZBTB24 KO-1 and 11 and 10-bp out-of-frame deletions in ZBTB24 KO-2.

Article Snippet: Briefly, IP samples were resolved on 8% denaturing PAGE gels along with purified human PARP1 (Aparptosis) as a positive control.

Techniques: Knockdown, Expressing, Derivative Assay, Western Blot, Control, Transfection, Plasmid Preparation, Staining, Flow Cytometry, Luciferase, Isolation, RNA Sequencing, Clone Assay

Journal: The Journal of Experimental Medicine

Article Title: Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome

doi: 10.1084/jem.20191688

Figure Lengend Snippet: PARP1 interacts with ZBTB24 in a PARylation-dependent manner and recruits ZBTB24 to sites of DNA damage. (A) Schematic representation of SILAC-based MS approach. GFP- or GFP-ZBTB24–expressing U2OS cells were labeled with Lys0 and Arg0 (L) or Lys8 and Arg10 (H), respectively. Lysates were subjected to GFP IP, and equal amounts of both IP fractions were mixed. Proteins in the IP fractions were digested by trypsin and subjected to MS analysis. A list of ZBTB24-interacting proteins, including the number of peptides and the interaction ratio from heavy (H)- over light (L)-labeled cell extracts as revealed by MS, is shown. (B) As in A, but with GFP- and GFP-PARP1–expressing U2OS cells. (C) Cells expressing GFP-ZBTB24, GFP-PARP1, and Myc-ZBTB24 or GFP-NLS and Myc-ZBTB24 were treated with either DMSO (Mock) or PARP inhibitor (PARPi). Whole-cell extracts (WCEs) were subjected to GFP IP followed by Western blot analysis of the indicated proteins. (D) IP of endogenous PARP1 in U2OS cells. IgG is a negative control. Blots were probed for ZBTB24 and PARP1. (E) Schematic representation of the laser microirradiation approach. (F) GFP-ZBTB24 or ZBTB24-GFP accumulate at γH2AX-decorated DNA damage tracks after transient expression and laser microirradiation in U2OS cells. Scale bar, 10 µm. (G) As in F, except that cells transiently expressing GFP-ZBTB24 and mCherry-NBS1 were treated with either DMSO (Mock) or PARPi before GFP-ZBTB24 and mCherry-NBS1 accumulation was monitored at the indicated time points after laser microirradiation. Scale bar, 10 µm. (H) Quantification of the results from G. The mean ± SEM of two to three independent experiments is shown. (I) As in G, except that cells were cotransfected with GFP-ZBTB24 and the indicated siRNAs. Scale bar, 10 µm. (J) Quantification of the results from I. The mean ± SEM of two to three independent experiments is shown (left). Western blot showing the knockdown efficiency of PARP1 and PARP2 (right).

Article Snippet: Briefly, IP samples were resolved on 8% denaturing PAGE gels along with purified human PARP1 (Aparptosis) as a positive control.

Techniques: Multiplex sample analysis, Expressing, Labeling, Western Blot, Negative Control, Knockdown

Journal: The Journal of Experimental Medicine

Article Title: Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome

doi: 10.1084/jem.20191688

Figure Lengend Snippet: PARG-dependent turnover of PAR chains modulates the accumulation of ZBTB24 at sites of DNA damage. The ZNF domain of ZBTB24 accumulates at sites of DNA damage in a PARP-dependent manner. ZBTB24 is not PARylated after DNA damage induction (related to and ). (A) U2OS cells transiently expressing GFP-ZBTB24 or GFP-NLS were treated with either DMSO (Mock) or PARPi. WCEs were subjected to GFP IP followed by Western blot analysis of the indicated proteins. (B) U2OS cells transfected with the indicated GFP-tagged proteins were treated with either DMSO (Mock) or PARPi. WCEs were prepared and subjected to Western blot analysis to assess total PAR levels. (C) Western blot analysis showing total PAR levels in U2OS cells transfected with the indicated siRNAs and transiently expressing GFP-ZBTB24. Tubulin is loading control. (D) GFP-ZBTB24 accumulation as monitored at the indicated time points after laser microirradiation in cells from C . Scale bar, 10 µm. (E) Quantification of the results from D. The mean ± SEM from two independent experiments is shown. (F) As in C , except that cells were cotransfected with a GFP-ZBTB24 and either an mCherry or mCherry-PARG expression vector were used. (G) As in D, except that cells from F were used. Scale bar, 10 µm. (H) Quantification of the results from G. The mean ± SEM from three independent experiments is shown. (I) U2OS cells transiently expressing GFP-tagged BAZ domains of ZBTB24 were treated with DMSO (Mock) or PARPi and subjected to laser microirradiation to follow GFP-BAZ accumulation at sites of DNA damage at the indicated time points after irradiation. Scale bar, 10 µm. (J) Quantification of I. The mean ± SEM from two independent experiments is shown. (K) As in I, except for the GFP-tagged ZNF domain of ZBTB24 (GFP-ZNF). Scale bar, 10 µm. (L) Quantification of K. The mean ± SEM from two independent experiments is shown. (M) U2OS cells expressing GFP were left untreated or treated with IR or MNNG. WCE were prepared and subjected to Western blot analysis for global PAR levels. (N) WCE extracts from M and from cells expressing GFP-ZBTB24 or GFP-PARP1 were subjected to GFP IP. Washes were performed under high-salt conditions to remove interacting proteins. Western blot analysis was done for the indicated proteins and PAR. The experiment was performed two times for PARP1 and four times for ZBTB24. Blots from a representative experiment are shown.

Article Snippet: Briefly, IP samples were resolved on 8% denaturing PAGE gels along with purified human PARP1 (Aparptosis) as a positive control.

Techniques: Expressing, Western Blot, Transfection, Control, Plasmid Preparation, Irradiation

Journal: The Journal of Experimental Medicine

Article Title: Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome

doi: 10.1084/jem.20191688

Figure Lengend Snippet: The ZNF domain in ZBTB24 interacts with PAR and mediates its recruitment to sites of DNA damage. (A) Schematic representation of isoform 1 of ZBTB24 and its BTB-, DNA-binding AT hook- and 8 × C 2 H 2 ZNF domain. Protein domains were separated as indicated and fused to GFP for functional analysis. (B) Western blot analysis of WCEs from U2OS cells expressing the indicated GFP-tagged ZBTB24 domains. (C) Accumulation of the indicated GFP-tagged ZBTB24 domain in laser microirradiated U2OS cells. Representative images of unirradiated and irradiated cells (taken at the indicated time point after irradiation) are shown. Scale bar, 10 µm. (D) HEK293T cells expressing the indicated GFP-tagged ZBTB24 domains were subjected to GFP IP. GFP-purified proteins were resolved by gel electrophoresis, blotted onto a membrane, renatured, and incubated with radioactive PAR ( 32 P-PAR). Recombinant (rec.) PARP1 is a positive control. (E) Lysates from U2OS cells transiently expressing either GFP-NLS or the indicated GFP-tagged ZBTB24 domains were subjected to GFP IP and Western blot analysis for the indicated proteins.

Article Snippet: Briefly, IP samples were resolved on 8% denaturing PAGE gels along with purified human PARP1 (Aparptosis) as a positive control.

Techniques: Binding Assay, Functional Assay, Western Blot, Expressing, Irradiation, Purification, Nucleic Acid Electrophoresis, Membrane, Incubation, Recombinant, Positive Control

Journal: The Journal of Experimental Medicine

Article Title: Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome

doi: 10.1084/jem.20191688

Figure Lengend Snippet: ZBTB24 stimulates PARP1-dependent PAR synthesis and protects PAR chain stability. (A) U2OS cells transfected with the indicated siRNAs were left untreated or exposed to IR. 5 min later, whole-cell extracts (WCEs) were prepared and subjected to Western blot analysis for DNA-PKcs and PAR. DNA-PKcs is a loading control. (B) Quantification of the results from A and a second independent experiment. The mean ± SEM is shown. The ratio of PAR/loading control signals per sample was normalized to that of the IR-exposed siLuc sample, which was set to 1. Statistical significance was calculated using Student’s t test (*, P < 0.05; **, P < 0.01). (C) Schematic of the PAR synthesis assay. (D) Recombinant PARP1 was incubated with a damaged DNA template and activated by NAD + in the presence of increasing concentrations of GST-ZBTB24, GST-ZBTB24 ΔZNF, or GST only. The presence of 10H-PAR chains and recombinant proteins was monitored by Western blot analysis. (E) Quantification of ZBTB24-dependent stimulation of PAR synthesis from D and two other independent experiments. The mean ± SD is shown. The signal of 10H-PAR for each sample containing GST-ZBTB24 or GST-ZBTB24 ΔZNF was normalized to that without GST-ZBTB24, which was set to 1. Statistical significance was calculated using Student’s t test (*, P < 0.05). (F) Schematic of the PAR protection assay. (G) Recombinant PARP1 was incubated with a damaged DNA template and activated by NAD + to generate PARylated PARP1. Increasing concentrations of GST-ZBTB24, GST-ZBTB24 ΔZNF, or GST alone were added, followed by incubation with PARG. The presence of 10H-PAR chains and recombinant proteins was monitored by Western blot analysis. (H) As in E, except that PAR protection was measured from G and another independent experiment. The mean ± SD is shown. Statistical significance was calculated using Student’s t test (*, P < 0.05).

Article Snippet: Briefly, IP samples were resolved on 8% denaturing PAGE gels along with purified human PARP1 (Aparptosis) as a positive control.

Techniques: Transfection, Western Blot, Control, Recombinant, Incubation

Journal: The Journal of Experimental Medicine

Article Title: Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome

doi: 10.1084/jem.20191688

Figure Lengend Snippet: Purification of recombinant ZBTB24 and PARP1 promotes XRCC4/LIG4 assembly and NHEJ at DNA damage sites. Related to and . (A) Coomassie-stained gel of recombinant GST, GST-tagged ZBTB24, and GST-tagged ZBTB24 ΔZNF, which were purified after expression in E. coli . The indicated samples from the purification procedure were loaded and run on a 4–12% polyacrylamide gel. (B) U2OS stably expressing GFP-XRCC4 were treated with DMSO (Mock) or PARPi and subjected to laser microirradiation. Representative images of unirradiated and irradiated cells (taken at the indicated time point after irradiation) are shown. Scale bar, 10 µm. (C) Quantification of B. The mean ± SEM from two independent experiments is shown. Statistical significance was calculated using Student’s t test (*, P < 0.05). (D) As in B, except that cells were transfected with the indicated siRNAs. Scale bar, 10 µm. (E) Quantification of D. The mean ± SEM from three to five independent experiments is shown. Statistical significance was calculated using Student’s t test (***, P < 0.001; ****, P < 0.0001). (F) Plasmid integration assays in U2OS cells transfected with indicated siRNAs. The mean ± SEM from two to four independent experiments is shown. Statistical significance was calculated using Student’s t test (**, P < 0.01; ****, P < 0.0001). (G) Accumulation of γH2AX and endogenous XRCC4 at sites of laser-inflicted DNA damage. U2OS cells were treated with the indicated siRNAs, subjected to laser microirradiation, and 10 min later, fixed and immunostained for γH2AX and endogenous XRCC4. Scale bar, 10 µm. (H) Quantification of endogenous XRCC4 levels in laser tracks from G. The mean ± SEM from two independent experiments is shown. Statistical significance was calculated using Student’s t test (****, P < 0.0001). (I) As in H, except for γH2AX. The mean ± SEM from two independent experiments is shown. Statistical significance was calculated using Student’s t test (ns, not significant).

Article Snippet: Briefly, IP samples were resolved on 8% denaturing PAGE gels along with purified human PARP1 (Aparptosis) as a positive control.

Techniques: Purification, Recombinant, Staining, Expressing, Stable Transfection, Irradiation, Transfection, Plasmid Preparation

Journal: The Journal of Experimental Medicine

Article Title: Loss of ZBTB24 impairs nonhomologous end-joining and class-switch recombination in patients with ICF syndrome

doi: 10.1084/jem.20191688

Figure Lengend Snippet: ZBTB24-defiecent cells show a-NHEJ signatures at repair junctions. (A–C) Mutational signatures (A), deletion sizes (B), and microhomology usage (in case of deletion formation; C) at repair junctions in the GC92 reporter for NHEJ. GC92 cells were transfected with the indicated siRNAs and I- Sce I expression vector. Repair junctions were amplified by PCR and Sanger sequenced. The bars represent data obtained from three independent experiments. (D) Western blot analysis of Zbtb24 and AID expression in wild-type CH12 cells (Zbtb24 +/+ ), Zbtb24 +/− , and Zbtb24 −/− clones stimulated to undergo CSR for 3 d with TGF-β, IL-4, and an anti-CD40 antibody. β-Actin is a loading control. (E) Flow cytometry analysis of cells from D. The percentage of IgA-expressing cells is indicated. Representative contour plots of three independent experiments are shown. (F) Quantification of cells from E. The mean ± SD from three independent experiments is shown. Data were normalized to wild-type Zbtb24 +/+ cells, which were set to 100%. Statistical significance was calculated using Student’s t test (***, P < 0.001; ****, P < 0.0001; ns, not significant). (G) Western blot analysis of Zbtb24 and AID expression in Zbtb24 −/− clones transduced with an empty retrovirus (pMX-PIE) or a retrovirus expressing mZbtbt24 and EGFP cDNA (pMX-mZtbtb24) and stimulated to undergo CSR for 3 d with TGF-β, IL-4, and an anti-CD40 antibody. β-Actin is a loading control. (H) Flow cytometry analysis of cells from G. Dot plots are gated on EGFP + cells. The percentage of IgA-expressing cells is indicated. Representative contour plots of two independent experiments are shown. (I) Quantification of cells from H. The mean ± SD from two independent experiments is shown. Data were normalized to uninfected wild-type Zbtb24 +/+ cells, which were set to 100%. –, not infected. Statistical significance was calculated using one-way ANOVA (*, P < 0.05; ***, P < 0.001). (J) Model for the role of ZBTB24 in DSB repair by NHEJ. ZBTB24 accumulates at DSBs, where it functions as a scaffold to protect PARP1-associated PAR-chains, which serve as a docking site for the LIG4-XRCC4 complex, facilitating efficient repair of DSBs via c-NHEJ. (K) Schematic illustrating that ZBTB24 loss leads to a shift from c-NHEJ to a-NHEJ and impaired CSR at AID-induced DSBs in B cells.

Article Snippet: Briefly, IP samples were resolved on 8% denaturing PAGE gels along with purified human PARP1 (Aparptosis) as a positive control.

Techniques: Transfection, Expressing, Plasmid Preparation, Amplification, Western Blot, Clone Assay, Control, Flow Cytometry, Transduction, Infection